Finnfacts
Search
DeutschFrancais
News Media Events Media Service Naturally Innovative
Companies
Economy facts Country Facts About Us Contacts

Innovations and industry
 
Gene research in Finland  


 

Chemical Industry:
FINLAND - A POSSIBLE WORLD LEADER IN RESEARCH INTO DISEASE GENES

by Eeva-Liisa Vallin

Finland is a unique target country for research into disease genes. In Finland there is a high standard of health care and the population is descended from the Finnish equivalent of Adam and Eve - there is a great deal of similarity in Finns’ genes compared with the United States for example.

Expertise in genetic research in Finland and the special features of the region have also been noted by the EU, because in September 2002 Finland received an appropriation of 13.5 million euros to coordinate a project into twin research that involves research workers from seven countries.

Pioneering research work into genes has been done for more than 20 years by Professor Leena Peltonen-Palotie and her group at Helsinki University and the Gene Department at the National Public Health Institute. She returned to her home country in the autumn of 2002 just to coordinate the European twin research after four years of research at the University of California.

“In Finland one in a hundred births are twins. In the whole of Europe there are 800,000 pairs of twins i.e. 1.6 million people,” she states.

Professor Peltonen-Palotie’s group has been doing research into typical Finnish illnesses and disease genes, such as the genes of AGU and Salla’s disease, which manifest themselves only in Finland, and also Finnish cardiovascular diseases.

In addition to the twin research that is now under way, i.e. understanding the genes of the population, the EU is financing at the same time a centre that is studying the genotype of mice and one unit that is examining the structure of proteins.

“It’s splendid that Finnish know-how has been recognized and Finland has been given the task of coordinating the most important of these projects in terms of human illnesses,” Peltonen-Palotie says.

Human genotype on the Internet

Professor Peltonen-Palotie says that all the genes of a human being and their structure have been made accessible on the Internet for everybody at the address http:/www.ncbi.nim.nih.gov/genome/guide/human/. The information is mainly used by research workers, but the ordinary person, too, can find interesting things on the pages, such as how many chromosomes a person has, what factors affect Down’s syndrome or a certain type of high hereditary cholesterol. What the multitude of causes are behind illnesses and what predisposes people to them. Why one person becomes sick and another does not.

“It’s quite certain that all of us will come down with some disease at some stage of our life, and the longer you live the more certain you are to fall ill,” says Peltonen-Palotie.

“The purpose of studying inherited diseases and genes is not to extend a person’s life but to identify at the level of the whole genotype the ‘gene profiles’ that influence the outbreak of different sicknesses together with environmental factors. With this knowledge it will be possible to aim at developing even more precise ‘highly selective medicines’, and even prevent a sickness totally or at least make the illness milder.”

The twin research will make it possible to study hereditariness and the effects of the environment. The twins being examined have developed similarly in the foetal stage, and also lived in the same type of environment for a long time after that. It is extremely important to know whether twins fall ill to the same inherited diseases, and if not, why.

Finland ahead of the USA

Professor Peltonen-Palotie says that the same kind of gene research relating to illnesses that is being carried out in Finland would not be possible in the United States, because their health care is inferior in its organization, epidemiological information is incomplete and the population is not as consistent in terms of its genotype compared with Finns. In this context the pioneering work in the study of cancer genes by Finns is worth mentioning.

Peltonen-Palotie believes, however, that the training of doctors focuses too little on an understanding of genes and genetic information. A genotype should be understood as much by specialists for internal medicine as by neurologists. Disturbances to the heart’s rhythm, clotted veins and thrombi can be caused by the genotype. Five genes that contribute to creating Alzheimer’s disease are now known.

“Finland and the Scandinavian countries have at their disposal a kind of position of special strength in biosciences, top-grade health care and the genetic and epidemiological research that is associated with it. We know an enormous amount about the events in people’s life cycle.”

Professor Peltonen-Palotie says that this advantage in health care and research should be exploited further. The best results would be achieved through wide-scale cooperation with different scientific fields.

“The IT sector, mathematicians and health care should cooperate more closely,” she stresses.

 

 

Published 2003

 
 

See also these
 

» EHS rules
» A drug for heart failure
» Super cellulose
» Genes for commercial uses
» Biotechnology - engine with many growth components
» Industry outlook - Chemical industry
» Finland - a possible world leader in research into disease genes
» Fast and safe tyre
» Injection-moulding challenging components


>> Back to index

 

 
 

 

 

 
Sitemap